OrbiMed’s BiomX PHGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,787,767
| Closed | -$993K | – | 109 |
|
|
2025
Q1 | $993K | Hold |
1,787,767
| – | – | 0.02% | 97 |
|
|
2024
Q4 | $1.31M | Hold |
1,787,767
| – | – | 0.03% | 102 |
|
|
2024
Q3 | $1.82M | Buy |
1,787,767
+410,402
| +30% | +$419K | 0.03% | 102 |
|
|
2024
Q2 | $4.63M | Buy |
1,377,365
+925,606
| +205% | +$3.11M | 0.09% | 89 |
|
|
2024
Q1 | $2.03M | Hold |
451,759
| – | – | 0.04% | 102 |
|
|
2023
Q4 | $1.26M | Sell |
451,759
-3,590
| -0.8% | -$10.1K | 0.03% | 101 |
|
|
2023
Q3 | $1.6M | Hold |
455,349
| – | – | 0.03% | 109 |
|
|
2023
Q2 | $1.64M | Buy |
455,349
+139,200
| +44% | +$501K | 0.03% | 114 |
|
|
2023
Q1 | $964K | Buy |
316,149
+34,800
| +12% | +$106K | 0.02% | 111 |
|
|
2022
Q4 | $525K | Hold |
281,349
| – | – | 0.01% | 113 |
|
|
2022
Q3 | $957 | Hold |
281,349
| – | – | 0.02% | 125 |
|
|
2022
Q2 | $2.05K | Hold |
281,349
| – | – | 0.04% | 127 |
|
|
2022
Q1 | $5.43M | Hold |
281,349
| – | – | 0.09% | 118 |
|
|
2021
Q4 | $4.5M | Hold |
281,349
| – | – | 0.06% | 137 |
|
|
2021
Q3 | $8.61M | Buy |
281,349
+50,000
| +22% | +$1.53M | 0.09% | 134 |
|
|
2021
Q2 | $12.6M | Hold |
231,349
| – | – | 0.13% | 115 |
|
|
2021
Q1 | $16.5M | Hold |
231,349
| – | – | 0.15% | 105 |
|
|
2020
Q4 | $14.8M | Hold |
231,349
| – | – | 0.13% | 112 |
|
|
2020
Q3 | $14.7M | Hold |
231,349
| – | – | 0.18% | 98 |
|
|
2020
Q2 | $12.8M | Hold |
231,349
| – | – | 0.18% | 90 |
|
|
2020
Q1 | $16.2M | Hold |
231,349
| – | – | 0.27% | 74 |
|
|
2019
Q4 | $22.4M | Buy |
+231,349
| New | +$22.4M | 0.32% | 62 |
|